Freenome and Roche partner on cancer screening technology for ex-US markets
Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US. Exceeding $200m,…
Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US. Exceeding $200m,…
Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes cited in the…
Princess Margaret Cancer Centre, part of Canada's University Health Network (UHN), has partnered with genomics company Helix to undertake the…
Breast cancer is the most diagnosed cancer in women worldwide. During October, breast cancer awareness month, community outreach should be…
Color Health, in collaboration with Google Cloud, has unveiled an initiative aimed at increasing the accessibility of breast cancer screening.…
Samsung C&T (SCT) and Samsung Electronics (SEC) have joined forces with Grail, a healthcare company, to advance the availability of…
A research team spearheaded by Harvard Medical School (HMS) in the US has created an AI tool, dubbed Pathology Image…
Accuray has introduced a new all-in-one adaptive radiotherapy solution, Accuray Stellar, tailored initially for the US market. This new technology…
October is Breast Cancer Awareness Month. Breast cancer is the most frequently diagnosed cancer in women globally. A key factor…
Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for Inlexzo (gemcitabine intravesical system),…